Source: Annual Congress 2002 - Treatment and outcome of acute respiratory failure in chronic disease
Disease area: Airway diseases

Abstract

The aim of the study was to estimate APACHE II and MPMo scores, as well as predicted death rates in patients with severe exacerbation of chronic obstructive pulmonary disease (COPD) at two consecutive admissions to Respiratory Intermediate Care Unit (RICU) with different outcomes of hospital treatment.
APACHE II score, predicted death rate by APACHE II score and predicted death rate by MPMo score were calculated in 34 patients at two consecutive admissions. At the first admission the patients had positive outcome, and all of them died at the consecutive hospitalization. Highly significant differences (p±]0.0001) in APACHE II scores (19±]4.5 ; 26±]7.8), in predicted death rates by APACHE II scores ( 27±]14% ; 45±]22%) and predicted death rates by MPMo scores ( 32±]23% ; 66±]28% ) were found between two admissions in RICU. It was concluded that APACHE II and MPMo scores are good predictors of outcome of patients with severe exacerbation of COPD.

Rating:

Share or cite this content

Citations should be made in the following way:
M. M. Mitic-Milikic, M. D. Vukcevic, L. Nagorni-Obradovic (Belgrade, Yugoslavia). APACHE II and MPMo scores in prediction of outcomes in patients with severe exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2002; 20: Suppl. 38, 609

Member's Comments

No comment yet.

Related content which might interest you: Comparison between predicted death rates by APACHE II and MPMo scores in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 83s Year: 2002 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Impact of exacerbation on health status deterioration in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001 An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 182s Year: 2002 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Eur Respir J 2008; 31: 563-570 Year: 2008 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 The comparisons of severity scoring systems for community acquired pneumonia patients with chronic obstructive pulmonary disease Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Does the chronic respiratory disease questionnaire (CRDQ) relate to hospital admission rates in chronic obstructive pulmonary disease (COPD) patients Source: Eur Respir J 2002; 20: Suppl. 38, 249s Year: 2002 Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Comparison of the different dyspnoea scales in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003 Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Subjective symptoms and functional performances in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Nursing challenges at home and in hospital Year: 2009 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013